Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Mantel-Cox Log-Rank Test01:19

The Mantel-Cox Log-Rank Test

598
The Mantel-Cox log-rank test is a widely used statistical method for comparing the survival distributions of two groups. It tests whether a statistically significant difference exists in survival times between the groups without assuming a specific distribution for the survival data, making it a non-parametric test. This flexibility makes the log-rank test particularly valuable in medical research and other fields where the timing of an event, such as death or disease recurrence, is of...
598
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

309
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
309
Censoring Survival Data01:09

Censoring Survival Data

261
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
261
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

202
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
202
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

311
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
311
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

284
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
284

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring performance trajectories in lung cancer surgery: a longitudinal study using the French national hospital database from 2020 to 2024.

BMJ health & care informatics·2026
Same author

Revisiting the Association Between Calcium Channel Blockers and Parkinson's Disease in the E3N Cohort.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Provincial variation and associated factors in adherence to cervical cancer screening in Canada: Evidence from the Canadian Partnership for Tomorrow's Health.

Journal of medical screening·2026
Same author

Factors associated with non-participation of preterm infants at two and five years in a large population-based French healthcare network.

BMC pediatrics·2026
Same author

Association between exposure to non-steroidal anti-inflammatory drugs in pregnancy and miscarriage risk: a French nationwide retrospective cohort study.

BMJ open·2026
Same author

Background incidence rates and observed-to-expected ratios of adverse events of special interest after covid-19 mRNA vaccination during pregnancy in France: a nationwide population-based study.

The Lancet regional health. Europe·2026

Related Experiment Video

Updated: Sep 24, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Analyzing cohort studies with interval-censored data: A new model-based linear rank-type test.

Rodolphe Jantzen1,2, Pascale Tubert-Bitter3, Philippe Broët1,2,3,4

  • 1CARTaGENE, CHU Ste-Justine Research Center, Montreal, Quebec, Canada.

Statistics in Medicine
|May 5, 2022
PubMed
Summary

This study introduces a new statistical test for analyzing survival data with interval censoring. The novel test offers a simpler alternative to existing methods, avoiding complex parameter choices and demonstrating good performance in simulations and real-world applications.

Keywords:
decreasing hazard ratiointerval-censored datareversed hazard risktwo-sample comparison

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

208

Related Experiment Videos

Last Updated: Sep 24, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

208

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Nonparametric Statistics

Background:

  • Comparing survival distributions with interval-censored data is challenging.
  • Existing methods, like the Harrington and Fleming family tests, require choosing a parameter (gamma) with unclear optimal values.
  • A need exists for robust, user-friendly tests for interval-censored survival data.

Purpose of the Study:

  • To propose a novel linear rank-type test for interval-censored data.
  • To derive the test from a proportional reversed hazard model.
  • To offer an alternative to gamma-family tests that bypasses parameter selection.

Main Methods:

  • Developed a novel linear rank-type test statistic.
  • Derived the test from a proportional reversed hazard model.
  • Investigated the test's relationship with decreasing hazard ratios.

Main Results:

  • The proposed test statistic effectively analyzes interval-censored data.
  • Simulation studies demonstrated the test's favorable performance.
  • The test identified important findings in breast cancer and drug user studies that other methods might miss.

Conclusions:

  • The new test is a valuable alternative for comparing survival distributions with interval-censored data.
  • It simplifies analysis by eliminating the need to choose a gamma parameter.
  • The test is versatile, easy to implement, and applicable to various medical and research scenarios.